A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

Clinical trial NCT03085069 · UNKNOWN

Trial details

NCT number: NCT03085069
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Respiratory Tract Neoplasms Nec Lung Disease Respiratory Tract Disease Neoplasm, Bronchial Carcinoma, Bronchogenic

Start date: 2017-05-03
Primary completion: 2020-08-20
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.